Meyka Pro banner
Labcorp Holdings Inc.

Labcorp Holdings Inc. (LH) Stock Overview

Explore Labcorp Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

LHNYSE
HealthcareMedical - Diagnostics & Research
$336.34
$3.53(1.06%)
U.S. Market opens in 61h 13m

Labcorp Holdings Inc. (LH)

Meyka AI Score

Z

Key Financials

Market Cap27.6B
P/E Ratio27.62
EPS (TTM)$16.85
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$327.93
3 Months$289.50
1 Year Target$276.89

LH Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Labcorp Holdings Inc. (NYSE: LH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Labcorp Holdings Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LH on the NYSE shows an RSI of 76.00, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $276.89 for the NYSE listing.

Key metrics behind Labcorp Holdings Inc.'s NYSE-traded stock include a P/E ratio of 27.62 and a market capitalization of 27.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LH on the NYSE.

Price Performance (NYSE: LH)

1-Day Change
1.007%
5-Day Change
5.93%
1-Month Change
20.31%
3-Month Change
31.44%
6-Month Change
18.92%
Year-to-Date (YTD) Change
33.99%
1-Year Change
21.55%
3-Year Change
55.90%
5-Year Change
28.84%
All-Time (Max) Change
1505.35%

Contact Information

336 229 1127
358 South Main Street, Burlington, NC, 27215

Company Facts

710,000 Employees
IPO DateMar 29, 1990
CountryUS
Actively Trading

Frequently Asked Questions